YAP and TAZ regulate adherens junction dynamics and endothelial cell distribution during vascular development

  1. Filipa Neto
  2. Alexandra Klaus-Bergmann
  3. Yu Ting Ong
  4. Silvanus Alt
  5. Anne-Clémence Vion
  6. Anna Szymborska
  7. Joana R Carvalho
  8. Irene Hollfinger
  9. Eireen Bartels-Klein
  10. Claudio A Franco
  11. Michael Potente  Is a corresponding author
  12. Holger Gerhardt  Is a corresponding author
  1. Max Delbrück Centre for Molecular Medicine, Germany
  2. Max Planck Institute for Heart and Lung Research, Germany
  3. Max Delbrück Center for Molecular Medicine, Germany
  4. Instituto de Medicina Molecular, Portugal

Abstract

Formation of blood vessel networks by sprouting angiogenesis is critical for tissue growth, homeostasis and regeneration. How endothelial cells arise in adequate numbers and arrange suitably to shape functional vascular networks is poorly understood. Here we show that YAP/TAZ promote stretch-induced proliferation and rearrangements of endothelial cells whilst preventing bleeding in developing vessels. Mechanistically, YAP/TAZ increase the turnover of VE-Cadherin and the formation of junction associated intermediate lamellipodia, promoting cell migration whilst maintaining barrier function. This is achieved in part by lowering BMP signalling. Consequently, the loss of YAP/TAZ in the mouse leads to stunted sprouting with local aggregation as well as scarcity of endothelial cells, branching irregularities and junction defects. Forced nuclear activity of TAZ instead drives hypersprouting and vascular hyperplasia. We propose a new model in which YAP/TAZ integrate mechanical signals with BMP signaling to maintain junctional compliance and integrity whilst balancing endothelial cell rearrangements in angiogenic vessels.

Article and author information

Author details

  1. Filipa Neto

    Integrative Vascular Biology, Max Delbrück Centre for Molecular Medicine, Berlin, Germany
    Competing interests
    No competing interests declared.
  2. Alexandra Klaus-Bergmann

    Integrative Vascular Biology, Max Delbrück Centre for Molecular Medicine, Berlin, Germany
    Competing interests
    No competing interests declared.
  3. Yu Ting Ong

    Angiogenesis and Metabolism Laboratory, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3407-2515
  4. Silvanus Alt

    Integrative Vascular Biology, Max Delbrück Centre for Molecular Medicine, Berlin, Germany
    Competing interests
    No competing interests declared.
  5. Anne-Clémence Vion

    Vascular Biology Laboratory, Max Delbrück Center for Molecular Medicine, Berlin, Germany
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2788-2512
  6. Anna Szymborska

    Integrative Vascular Biology, Max Delbrück Centre for Molecular Medicine, Berlin, Germany
    Competing interests
    No competing interests declared.
  7. Joana R Carvalho

    Vascular Morphogenesis Laboratory, Instituto de Medicina Molecular, Lisbon, Portugal
    Competing interests
    No competing interests declared.
  8. Irene Hollfinger

    Integrative Vascular Biology, Max Delbrück Centre for Molecular Medicine, Berlin, Germany
    Competing interests
    No competing interests declared.
  9. Eireen Bartels-Klein

    Integrative Vascular Biology, Max Delbrück Centre for Molecular Medicine, Berlin, Germany
    Competing interests
    No competing interests declared.
  10. Claudio A Franco

    Vascular Morphogenesis Laboratory, Instituto de Medicina Molecular, Lisbon, Portugal
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2861-3883
  11. Michael Potente

    Angiogenesis and Metabolism Laboratory, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany
    For correspondence
    michael.potente@mpi-bn.mpg.de
    Competing interests
    No competing interests declared.
  12. Holger Gerhardt

    Integrative Vascular Biology, Max Delbrück Centre for Molecular Medicine, Berlin, Germany
    For correspondence
    holger.gerhardt@mdc-berlin.de
    Competing interests
    Holger Gerhardt, Reviewing editor, eLife.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3030-0384

Funding

H2020 European Research Council (Consolidator Grant Reshape 311719)

  • Holger Gerhardt

H2020 European Research Council (Starting Grant ANGIOMET (311546))

  • Michael Potente

Deutsche Forschungsgemeinschaft (SFB 834)

  • Michael Potente

Excellence Cluster Cardiopulmonary System (EXC 147/1)

  • Michael Potente

LOEWE Research Initiatives Network (Ub-Net)

  • Michael Potente

Stiftung Charité

  • Michael Potente

European Molecular Biology Organization (Young Investigator Programme)

  • Michael Potente

Portugal2020 Program (LISBOA-01-0145-FEDER-00739)

  • Claudio A Franco

Fundação para a Ciência e a Tecnologia (SFRH/BD/51287/2010)

  • Filipa Neto

European Molecular Biology Organization (Long-Term Fellowship ALTF 1625-2014)

  • Anna Szymborska

Deutsches Zentrum für Herz-Kreislaufforschung (REMODEL)

  • Alexandra Klaus-Bergmann
  • Anne-Clémence Vion
  • Eireen Bartels-Klein
  • Holger Gerhardt

H2020-TWINN-2015 (ReTuBi-692322)

  • Claudio A Franco

Fundação para a Ciência e a Tecnologia (SFRH/BD/52224/2013​​)

  • Joana R Carvalho

Fundação para a Ciência e a Tecnologia (FCT Investigator IF/00412/2012)

  • Claudio A Franco

H2020 European Research Council (EC-ERC Starting Grant AXIAL.EC-679368)

  • Claudio A Franco

Fundação para a Ciência e a Tecnologia (EXPL/BEX-BCM/2258/2013)

  • Claudio A Franco

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All procedures involving handling of living animals were performed in accordance with: the United Kingdom's Home Office Animal Act 1986 under the authority of project licence PPL 80/2391 (experiments done in LRI-CRUK); the German animal protection law with approval by the regional offices for health and social services LaGeSo, under the animal licence IC113 G 0117/15 (experiments done in MDC); institutional guidelines and laws, following protocols approved by local animal ethics committees and authorities (B2/1061; Regierungspraesidium Darmstadt) (experiments done at the MPI for Heart and Lung Research).

Copyright

© 2018, Neto et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 10,984
    views
  • 1,832
    downloads
  • 193
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Filipa Neto
  2. Alexandra Klaus-Bergmann
  3. Yu Ting Ong
  4. Silvanus Alt
  5. Anne-Clémence Vion
  6. Anna Szymborska
  7. Joana R Carvalho
  8. Irene Hollfinger
  9. Eireen Bartels-Klein
  10. Claudio A Franco
  11. Michael Potente
  12. Holger Gerhardt
(2018)
YAP and TAZ regulate adherens junction dynamics and endothelial cell distribution during vascular development
eLife 7:e31037.
https://doi.org/10.7554/eLife.31037

Share this article

https://doi.org/10.7554/eLife.31037

Further reading

    1. Cell Biology
    Satoshi Ninagawa, Masaki Matsuo ... Kazutoshi Mori
    Research Advance

    How the fate (folding versus degradation) of glycoproteins is determined in the endoplasmic reticulum (ER) is an intriguing question. Monoglucosylated glycoproteins are recognized by lectin chaperones to facilitate their folding, whereas glycoproteins exposing well-trimmed mannoses are subjected to glycoprotein ER-associated degradation (gpERAD); we have elucidated how mannoses are sequentially trimmed by EDEM family members (George et al., 2020; 2021 eLife). Although reglucosylation by UGGT was previously reported to have no effect on substrate degradation, here we directly tested this notion using cells with genetically disrupted UGGT1/2. Strikingly, the results showed that UGGT1 delayed the degradation of misfolded substrates and unstable glycoproteins including ATF6α. An experiment with a point mutant of UGGT1 indicated that the glucosylation activity of UGGT1 was required for the inhibition of early glycoprotein degradation. These and overexpression-based competition experiments suggested that the fate of glycoproteins is determined by a tug-of-war between structure formation by UGGT1 and degradation by EDEMs. We further demonstrated the physiological importance of UGGT1, since ATF6α cannot function properly without UGGT1. Thus, our work strongly suggests that UGGT1 is a central factor in ER protein quality control via the regulation of both glycoprotein folding and degradation.

    1. Biochemistry and Chemical Biology
    2. Cell Biology
    Senem Ntourmas, Martin Sachs ... Dominic B Bernkopf
    Research Article

    Activation of the Wnt/β-catenin pathway crucially depends on the polymerization of dishevelled 2 (DVL2) into biomolecular condensates. However, given the low affinity of known DVL2 self-interaction sites and its low cellular concentration, it is unclear how polymers can form. Here, we detect oligomeric DVL2 complexes at endogenous protein levels in human cell lines, using a biochemical ultracentrifugation assay. We identify a low-complexity region (LCR4) in the C-terminus whose deletion and fusion decreased and increased the complexes, respectively. Notably, LCR4-induced complexes correlated with the formation of microscopically visible multimeric condensates. Adjacent to LCR4, we mapped a conserved domain (CD2) promoting condensates only. Molecularly, LCR4 and CD2 mediated DVL2 self-interaction via aggregating residues and phenylalanine stickers, respectively. Point mutations inactivating these interaction sites impaired Wnt pathway activation by DVL2. Our study discovers DVL2 complexes with functional importance for Wnt/β-catenin signaling. Moreover, we provide evidence that DVL2 condensates form in two steps by pre-oligomerization via high-affinity interaction sites, such as LCR4, and subsequent condensation via low-affinity interaction sites, such as CD2.